Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice

Yale Journal of Biology and Medicine

Volumn 70, Issue 5-6, 1997, Pages 549-554

  Weckbecker, Gisbert ^a   Raulf, Friedrich ^a   Bodmer, David ^a   Bruns, Christian ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LONG ACTING DRUG; OCTREOTIDE; RECEPTOR SUBTYPE; SMS PA LAR; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; CARCINOMA CELL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS CARCINOMA; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOMA; CELL DIVISION; HUMANS; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; OCTREOTIDE; PANCREATIC NEOPLASMS; RECEPTORS, SOMATOSTATIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

AGOUTI PACA; ANIMALIA; MUS MUSCULUS;

EID: 0031392104     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Lamberts, S.W.J., Krenning, E.P., and Reubi, J.-C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr. Rev. 12:450-482, 1991.
2. Weckbecker G., Raulf, F., Stolz, B., and Bruns, C. Somatostatin analogs for diagnosis and treatment of cancer Pharmacol. Ther. 60:245-264, 1993.
3. Buscail, L., Delesque, N., Estève, J.-P., Saint-Laurent, N., Prats, H., Clerc, P., Robberecht, P., Bell, G.I., Liebow, C., Schally, A.V., Vaysse, N., and Susini, C. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues:mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc. Natl. Acad. Sci. USA 91:2315-2319, 1994.
4. Srikant, C.B. and Shen, S.-H. Octapeptide somatostatin analog SMS 201-995 induces translocation of intracellular PTP1C to membranes in MCF-7 human breast adenocarcinoma cells. Endocrinology 137:3461-3468, 1996.
5. Serri, O., Brazeau, P., Kachra, Z., and Posner, B. Octreotide inhibits insulin-like growth factor-I hepatic gene expression in the hypophysectomized rat:evidence for a direct and indirect mechanism of action. Endocrinology 130:1816-1821, 1992.
6. Huynh, H.T. and Pollak, M.N. Enhancement of tamoxifen-induced suppression of insulin-like growth factor I gene expression and serum level by somatostatin analogue. Biochem. Biophys. Res. Comm. 203:253-259, 1994.
7. Gillespie, J., Poston, G.J., Schachter, M., and Guillou, P.J. Human pancreatic cancer cell lines do not express receptors for somatostatin. Br. J. Cancer 66:483-487, 1992.
8. Radulovic, S., Comaru-Schally, A.M., Milovanovic, S., and Schally, A.V. Somatostatin analog RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice. Pancreas 8:88-97, 1993.
9. Weckbecker, G., Liu, R., Tolcsvai, L., and Bruns, C. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro. Cancer Res. 52:4973-4978, 1992.
10. Raulf, F., Pérez, J., Hoyer, D., and Bruns, C. Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue. Digestion 55(Suppl. 3):46-53, 1994.
11. Barrie, R., Woltering, E.A., Hajarizadeh, H., Mueller, C., Ure, T, and Fletcher, W.S. Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent. J. Surg. Res. 55:446-450, 1993.
12. Reubi, J.C., Horisberger, and U., Laissue, J. High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor-host interaction? Int. J. Cancer 56:681-688, 1994.
13. Danesi, R. and Del Tacca, M. Effects of octreotide on angiogenesis In: Scarpignato, C., ed. Octreotide: From basic science to clinical medicine. Prog. Basic Clin. Pharmacol. Vol. 10, Basel: Karger; 1996, pp. 234-245.
14. Upp, J. R., Olson, D., Jr., Poston, G. J., Alexander, R. W., Townsend, C. M., and Thompson J. C. Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995. Am. Surg. 115:29-35, 1988.
15. Fisher, W.E., Muscarella, P., O'Dorisio, T.M., O'Dorisio, M.S., Kim, J.A., Doran, T.A., Sabourin, C.L., and Schirmer, W.J. Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide. Surgery 120:234-241, 1996.
16. Ebert, M., Büchler, M., Fries, H., and Berger, H.G. Advanced pancreatic cancer: high-dose somatostatin-analogue treatment. Gastroenterology 104:A302, 1993.